Cookson Peirce & Co. Inc. Makes New $1.27 Million Investment in Astera Labs, Inc. $ALAB

Key Points

• Cookson Peirce & Co. Inc. has made a new investment of approximately $1.27 million in Astera Labs, purchasing 14,042 shares in the second quarter.
• Astera Labs recently reported earnings of $0.44 EPS, exceeding analyst estimates, with a revenue of $191.93 million, a 149.5% increase year-over-year.
• Insiders, including the CFO and CEO, sold significant amounts of their stock, with total insider sales amounting to over $192 million in the last 90 days.

Cookson Peirce & Co. Inc. purchased a new position in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 14,042 shares of the company's stock, valued at approximately $1,270,000.

Several other large investors also recently modified their holdings of the business. Vanguard Group Inc. increased its holdings in shares of Astera Labs by 0.9% in the first quarter. Vanguard Group Inc. now owns 9,297,476 shares of the company's stock worth $554,780,000 after acquiring an additional 85,846 shares in the last quarter. Alliancebernstein L.P. increased its holdings in shares of Astera Labs by 114.2% in the first quarter. Alliancebernstein L.P. now owns 8,401,019 shares of the company's stock worth $501,289,000 after acquiring an additional 4,478,741 shares in the last quarter. Atreides Management LP boosted its position in shares of Astera Labs by 153.3% during the first quarter. Atreides Management LP now owns 4,652,264 shares of the company's stock worth $277,601,000 after buying an additional 2,815,614 shares during the period. Fred Alger Management LLC boosted its position in shares of Astera Labs by 13.0% during the first quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company's stock worth $93,087,000 after buying an additional 179,638 shares during the period. Finally, FengHe Fund Management Pte. Ltd. acquired a new position in shares of Astera Labs during the second quarter worth about $106,772,000. 60.47% of the stock is currently owned by institutional investors.

Insider Activity

In other news, CFO Michael Truett Tate sold 100,000 shares of Astera Labs stock in a transaction on Thursday, August 7th. The stock was sold at an average price of $171.38, for a total value of $17,138,000.00. Following the transaction, the chief financial officer owned 518,996 shares in the company, valued at approximately $88,945,534.48. This trade represents a 16.16% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Jitendra Mohan sold 152,517 shares of Astera Labs stock in a transaction on Thursday, August 7th. The shares were sold at an average price of $170.33, for a total value of $25,978,220.61. Following the completion of the transaction, the chief executive officer owned 450,001 shares in the company, valued at approximately $76,648,670.33. The trade was a 25.31% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 1,092,997 shares of company stock worth $192,231,120. 12.50% of the stock is currently owned by insiders.

Astera Labs Price Performance

Astera Labs stock opened at $154.85 on Thursday. The stock's fifty day moving average price is $197.75 and its two-hundred day moving average price is $129.89. Astera Labs, Inc. has a one year low of $47.13 and a one year high of $262.90. The firm has a market cap of $25.74 billion, a PE ratio of 276.52, a price-to-earnings-growth ratio of 3.92 and a beta of 1.43.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, topping analysts' consensus estimates of $0.33 by $0.11. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The firm had revenue of $191.93 million for the quarter, compared to analyst estimates of $172.46 million. During the same quarter last year, the company earned $0.13 EPS. The company's revenue was up 149.5% on a year-over-year basis. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Sell-side analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several brokerages recently commented on ALAB. Northland Securities cut Astera Labs from an "outperform" rating to a "market perform" rating and set a $120.00 price target for the company. in a research report on Tuesday, July 22nd. Weiss Ratings reiterated a "hold (c-)" rating on shares of Astera Labs in a research note on Wednesday, October 8th. Needham & Company LLC increased their target price on Astera Labs from $100.00 to $170.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. Barclays reiterated an "equal weight" rating and set a $155.00 target price on shares of Astera Labs in a research note on Monday. Finally, CICC Research assumed coverage on Astera Labs in a research note on Friday, August 29th. They set an "outperform" rating and a $190.00 target price on the stock. Fourteen equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $162.06.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.